-
Review
January 5, 2023
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
- Clin Mol Hepatol. 2023;29(2):197-205.
-
Review
December 22, 2022
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, et al.
- Clin Mol Hepatol. 2023;29(2):206-216.
-
Review
December 28, 2022
- Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
- Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, et al.
- Clin Mol Hepatol. 2023;29(2):217-229.
-
Review
January 30, 2023
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
- Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, et al.
- Clin Mol Hepatol. 2023;29(2):230-241.
-
Review
March 20, 2023
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
- Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, et al.
- Clin Mol Hepatol. 2023;29(2):242-251.
-
Review
March 10, 2023
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(2):252-262.
-
Review
January 19, 2023
- The role of different viral biomarkers on the management of chronic hepatitis B
- Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
- Clin Mol Hepatol. 2023;29(2):263-276.
-
Review
January 30, 2023
- Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
- Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, et al.
- Clin Mol Hepatol. 2023;29(2):277-292.
-
Review
February 1, 2023
- Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
- Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, et al.
- Clin Mol Hepatol. 2023;29(2):293-319.
-
Review
February 1, 2023
- Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
- Shang-Chin Huang, Chun-Jen Liu
- Clin Mol Hepatol. 2023;29(2):320-331.
-
Original Article
November 21, 2022
- Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
- Kathryn Jane Waller, Hajar Saihi, Wenhao Li, et al.
- Clin Mol Hepatol. 2023;29(2):417-432.
-
Original Article
January 4, 2023
- Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
- Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, et al.
- Clin Mol Hepatol. 2023;29(2):433-452.
-
Original Article
February 1, 2023
- Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
- Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, et al.
- Clin Mol Hepatol. 2023;29(2):453-464.
-
Original Article
February 20, 2023
- Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions
- Jing Yang, Xujiao Tang, Zhu Liang, et al.
- Clin Mol Hepatol. 2023;29(2):465-481.
-
Original Article
January 5, 2023
- Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
- Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, et al.
- Clin Mol Hepatol. 2023;29(2):482-495.
-
Original Article
March 6, 2023
- Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
- Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, et al.
- Clin Mol Hepatol. 2023;29(2):496-509.
This archive contains links to the full-text of all issues of Clin Mol Hepatol.
Current issue
|
All issues
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
First decision
09 Days
Publication after acceptance
07 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
Viewed By
4154Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease Viewed By
3564Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection Viewed By
2827Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis Viewed By
2782Recent updates on the management of autoimmune hepatitis Viewed By
2705Identification of high-risk subjects in nonalcoholic fatty liver disease
- MOST CITED (2021-2023)
Cited By
99KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease Cited By
42Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis Cited By
42From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? Cited By
40Obesity and the risk of primary liver cancer: A systematic review and meta-analysis Cited By
38The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
|
|||||||
